Literature DB >> 4009488

5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs.

B M Clancy, S Maayani.   

Abstract

The 5-HT2 receptor in isolated rabbit thoracic aorta was characterized by examining the relationships between structure and activity of nine tryptamine analogs. All assays were conducted after blockade of the alpha adrenergic receptor and inactivation of the neuronal uptake-1 system and monoamine oxidase. Seven of the analogs tested were agonists. 6-Hydroxytryptamine and 7-hydroxytryptamine showed little or no agonist activity in this preparation. The pA2 of spiperone was independent of the agonist assayed and defined the receptor activated by each agonist as the 5-HT2 receptor. The dissociation constant (KA) and relative intrinsic efficacy were determined for each agonist. The KA and relative intrinsic efficacy values for 5-hydroxytryptamine were 0.25 microM and 1, respectively. The KA and relative intrinsic efficacy values for 5-methoxytryptamine were 0.14 microM and 0.86, respectively, and were not significantly different from those for 5-hydroxytryptamine. The other five analogs were partial agonists. N-Methyl-5-hydroxytryptamine and bufotenine had relative intrinsic efficacies of about 0.3 and KA values not statistically different from the KA value for 5-hydroxytryptamine. Tryptamine, 5-methyltryptamine and alpha-methyl-tryptamine had KA values of about 1 microM and relative intrinsic efficacies of 0.6, 0.6 and 0.4, respectively. These results revealed the differential effects of structural changes on drug affinity and intrinsic efficacy. This information will be applicable in the design of selective agonists or antagonists for the classification of less well defined 5-hydroxytryptamine receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009488

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.

Authors:  G R Martin; P Leff; D Cambridge; V J Barrett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

3.  A 5-hydroxytryptamine receptor in human atrium.

Authors:  A J Kaumann; L Sanders; A M Brown; K J Murray; M J Brown
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

4.  Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors.

Authors:  P R Saxena; D J Duncker; A H Bom; J Heiligers; P D Verdouw
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

6.  Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

7.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

8.  5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.

Authors:  H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

9.  Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.